In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Abaxis, Inc.
(NASDAQ:ABAX), PRA Health Sciences, Inc. (NASDAQ:PRAH), Brighthouse
Financial, Inc. (NASDAQ:BHF), Investors Bancorp, Inc.
(NASDAQ:ISBC), Cypress Semiconductor Corporation (NASDAQ:CY), and
Sage Therapeutics, Inc. (NASDAQ:SAGE) including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified
certified analyst research.
Complimentary Access: Research
Reports
Full copies of recently published
reports are available to readers at the links below.
ABAX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ABAX
PRAH DOWNLOAD:
http://Fundamental-Markets.com/register/?so=PRAH
BHF DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BHF
ISBC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ISBC
CY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CY
SAGE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SAGE
(You may have to copy and paste the link into
your browser and hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Abaxis, Inc. (NASDAQ:ABAX), PRA Health Sciences, Inc.
(NASDAQ:PRAH), Brighthouse Financial, Inc. (NASDAQ:BHF), Investors
Bancorp, Inc. (NASDAQ:ISBC), Cypress Semiconductor Corporation
(NASDAQ:CY), and Sage Therapeutics, Inc. (NASDAQ:SAGE) on a
fundamental level and outlines the overall demand for their
products and services in addition to an in-depth review of the
business strategy, management discussion, and overall direction
going forward. Several excerpts from the recently released reports
are available to today’s readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 5, 2017. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All amounts in
millions (except per share amounts).
-----------------------------------------
ABAXIS, INC. (ABAX) REPORT
OVERVIEW
Abaxis' Recent
Financial Performance
For the three months ended June 30, 2017 vs June
30, 2016, Abaxis reported revenue of $58.3 vs $57.7 (up 1.0%),
diluted earnings per share $0.28 vs $0.30 (down 6.7%), and
dividends per share $0.14 vs $0.12 (up 16.7%). For the twelve
months ended December 31, 2016 vs December 31, 2015, Abaxis
reported revenue of $227.2 vs $218.9 (up 3.8%), diluted earnings
per share $1.44 vs $1.38 (up 4.4%), and dividends per share $0.52
vs $0.44 (up 18.2%).
To read the full Abaxis, Inc. (ABAX) report,
download it here:
http://Fundamental-Markets.com/register/?so=ABAX
-----------------------------------------
PRA HEALTH SCIENCES, INC. (PRAH) REPORT
OVERVIEW
PRA Health Sciences'
Recent Financial Performance
For the three months ended September 30, 2017 vs
September 30, 2016, PRA Health Sciences reported revenue of $582 vs
$453 (up 28.5%), diluted earnings per share $0.73 vs $0.49 (up
49.0%). For the twelve months ended December 31, 2016 vs December
31, 2015, PRA Health Sciences reported revenue of $1,812 vs $1,614
(up 12.3%), diluted earnings per share $1.06 vs $1.29 (down
17.8%).
To read the full PRA Health Sciences, Inc.
(PRAH) report, download it here:
http://Fundamental-Markets.com/register/?so=PRAH
-----------------------------------------
BRIGHTHOUSE FINANCIAL, INC. (BHF) REPORT
OVERVIEW
Brighthouse's Recent
Financial Performance
For the three months ended June 30, 2017 vs June
30, 2016, Brighthouse reported revenue of $2,025 vs -$584, pro
forma earnings per share $2.05 vs -$11.88.
To read the full Brighthouse Financial, Inc.
(BHF) report, download it here:
http://Fundamental-Markets.com/register/?so=BHF
-----------------------------------------
INVESTORS BANCORP, INC. (ISBC) REPORT
OVERVIEW
Investors Bancorp's
Recent Financial Performance
For the three months ended June 30, 2017 vs June
30, 2016, Investors Bancorp reported interest and dividend income
of $216 vs $195 (up 10.8%), diluted earnings per share $0.14 vs
$0.15 (down 6.7%). For the twelve months ended December 31, 2016 vs
December 31, 2015, Investors Bancorp reported interest and dividend
income of $794 vs $732 (up 8.5%), diluted earnings per share $0.64
vs $0.55 (up 16.4%).
To read the full Investors Bancorp, Inc. (ISBC)
report, download it here:
http://Fundamental-Markets.com/register/?so=ISBC
-----------------------------------------
CYPRESS SEMICONDUCTOR CORPORATION (CY)
REPORT OVERVIEW
Cypress Semiconductor's
Recent Financial Performance
For the three months ended October 1, 2017 vs
October 2, 2016, Cypress Semiconductor reported revenue of $605 vs
$524 (up 15.5%), diluted earnings per share $0.03 vs $0.03
(unchanged), and dividends per share $0.11 vs $0.11 (unchanged).
For the twelve months ended January 1, 2017 vs January 3, 2016,
Cypress Semiconductor reported revenue of $1,923 vs $1,608 (up
19.6%), diluted earnings per share -$2.15 vs -$1.25, and dividends
per share $0.44 vs $0.44 (unchanged).
To read the full Cypress Semiconductor
Corporation (CY) report, download it here:
http://Fundamental-Markets.com/register/?so=CY
-----------------------------------------
SAGE THERAPEUTICS, INC. (SAGE) REPORT
OVERVIEW
Sage Therapeutics's
Recent Financial Performance
For the three months ended June 30, 2017 vs June
30, 2016, Sage Therapeutics reported diluted earnings per share
-$1.97 vs -$1.15. For the twelve months ended December 31, 2016 vs
December 31, 2015, Sage Therapeutics reported diluted earnings per
share -$4.75 vs -$3.40.
To read the full Sage Therapeutics, Inc. (SAGE)
report, download it here:
http://Fundamental-Markets.com/register/?so=SAGE
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world’s leading
brokerages for over a decade—and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets’ roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets’ roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets’ Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
© 2017 Fundamental Markets. All Rights
Reserved. For republishing permissions, please contact a partner
network manager at
partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst®
are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are
registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
Cypress Semiconductor (NASDAQ:CY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cypress Semiconductor (NASDAQ:CY)
Historical Stock Chart
From Sep 2023 to Sep 2024